These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 32318353)
1. Retraction: The role of microRNAs in the tumorigenesis of ovarian cancer. Frontiers Editorial Office Front Oncol; 2020; 10():585. PubMed ID: 32318353 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA H19 promotes tumorigenesis of ovarian cancer by sponging miR-675 [Retraction]. Int J Clin Exp Pathol; 2019; 12(2):679. PubMed ID: 32256932 [TBL] [Abstract][Full Text] [Related]
4. Retraction note to four articles published in Cui Q World J Orthop; 2018 Mar; 9(3):58-59. PubMed ID: 29564215 [TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer [Retraction]. Int J Clin Exp Med; 2015; 8(7):11862. PubMed ID: 26380028 [TBL] [Abstract][Full Text] [Related]
7. Retraction Note. Kowsar Publishing Company Iran Red Crescent Med J; 2016 Mar; 18(3):e43586. PubMed ID: 27830082 [TBL] [Abstract][Full Text] [Related]
8. The role of fenhexamid on the proliferation of ovarian cancer BG-1 cells [Retraction]. Int J Clin Exp Pathol; 2020; 13(3):634. PubMed ID: 32269705 [TBL] [Abstract][Full Text] [Related]
9. Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer [Retraction]. Int J Clin Exp Pathol; 2013; 6(12):3050. PubMed ID: 29874307 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer [Retraction]. Am J Transl Res; 2021; 13(8):9918. PubMed ID: 34540129 [TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells [Retraction]. Int J Clin Exp Pathol; 2021; 14(7):856. PubMed ID: 34367418 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a [Retraction]. Am J Cancer Res; 2023; 13(2):711. PubMed ID: 36895963 [TBL] [Abstract][Full Text] [Related]
13. miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells [Retraction]. Am J Transl Res; 2022; 14(1):695. PubMed ID: 35173889 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer [Retraction]. Am J Transl Res; 2022; 14(10):7621. PubMed ID: 36398227 [TBL] [Abstract][Full Text] [Related]
16. Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis [Retraction]. Am J Transl Res; 2016; 8(10):4510. PubMed ID: 27830036 [TBL] [Abstract][Full Text] [Related]
17. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy [Retraction]. Int J Clin Exp Med; 2017; 10(9):14159. PubMed ID: 29874332 [TBL] [Abstract][Full Text] [Related]
18. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy [Retraction]. Int J Clin Exp Pathol; 2017; 10(9):10152. PubMed ID: 29874309 [TBL] [Abstract][Full Text] [Related]
19. Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]. Onco Targets Ther; 2016; 9():5699. PubMed ID: 27703370 [TBL] [Abstract][Full Text] [Related]
20. Retraction: Musculoskeletal Disorders: Epidemiology and Treatment Seeking Behavior of Secondary School Students in a Nigerian Community. Indian J Community Med; 2016; 41(1):78. PubMed ID: 26917882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]